We are live on
!
Find out more
Sana Biotechnology
SANA
SANA
123 hedge funds and large institutions have $804M invested in Sana Biotechnology in 2023 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 38 increasing their positions, 41 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
6,590% more call options, than puts
Call options by funds: $8.23M | Put options by funds: $123K
88% more capital invested
Capital invested by funds: $427M → $804M (+$377M)
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
30% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 10
3% more funds holding
Funds holding: 120 → 123 (+3)
2.16% more ownership
Funds ownership: 68.31% → 70.47% (+2.2%)
7% less repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 41
Holders
123
Holders Change
+3
Holders Change %
+2.5%
% of All Funds
1.93%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
13
Increased
38
Reduced
41
Closed
10
Calls
$8.23M
Puts
$123K
Net Calls
+$8.11M
Net Calls Change
+$8.12M
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$43.2M |
| 2 |
Capital World Investors
Los Angeles,
California
|
+$8.83M |
| 3 |
CC
Casdin Capital
New York
|
+$4.32M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$3.53M |
| 5 |
Millennium Management
New York
|
+$1.49M |
